No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Dr Murdoc Khaleghi Appointed CMO at Base

To Support Expanded Personalized Biomarker Testing and Health Recommendations

Editor: What To Know

  • Dr Murdoc Khaleghi is a founding member of the Everlywell team and serves as Medical Director at several health tech startups including WellnessFX, Healium, NeuroTrack, and Me Biosciences.
  • “I’m excited to join Base and work alongside Lola, a passionate and forward-thinking visionary, to continue providing individuals the tools and resources to make informed decisions about their health.
  • Last month, the company integrated with Amazon to further advance the personalized health experience and allow users to tailor their shopping choices based on their health goals and lab results.

Dr Murdoc Khaleghi is a founding member of the Everlywell team and serves as Medical Director at several health tech startups including WellnessFX, Healium, NeuroTrack, and Me Biosciences.

Dr Murdoc Khaleghi will oversee testing operations, address medical questions from users and help identify new critical health biomarkers to expand the company’s consumer products.

“We are thrilled to add Dr. Khaleghi to our growing team at Base. His impressive background will help boost our medical team, as well as advance our mission to bridge the gap between science and consumers,” said Lola Priego, Founder and CEO of Base. “With his expertise, we aim to create an all encompassing support system for people looking to take control of their health through prevention and personalization.”

Base launched in February 2021 after months of beta testing with $3.4M in seed funding and has experienced tremendous growth since, due in part to the consumer shift to embrace at-home and personalized healthcare. The company uses advanced technology to analyze a blood or saliva sample to determine hormone, vitamin and nutrient deficiencies and address health concerns in five key areas; diet, stress, energy, sleep and sex drive. A diagnosis is then delivered to users via the Base app, along with data-driven suggestions to improve any biomarker levels that are sub-optimal. Personalized recommendations span nutrition, supplement, and lifestyle changes

Last month, the company integrated with Amazon to further advance the personalized health experience and allow users to tailor their shopping choices based on their health goals and lab results. The recommended vitamins and supplements can be added to users’ Amazon shopping cart straight from the Base app, and are vetted and approved by the medical team, which is now led by Dr. Khaleghi.

“Having worked in diagnostics for more than a decade, I have witnessed the power of biomarker testing for overall health improvement and research within the space,” said Dr. Khaleghi. “I’m excited to join Base and work alongside Lola, a passionate and forward-thinking visionary, to continue providing individuals the tools and resources to make informed decisions about their health.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy